Richard Newitter
Stock Analyst at Truist Securities
(4.39)
# 316
Out of 4,884 analysts
366
Total ratings
54.59%
Success rate
16.15%
Average return
Main Sectors:
Stocks Rated by Richard Newitter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNDM Tandem Diabetes Care | Initiates: Hold | $24 | $16.78 | +43.03% | 1 | Jun 16, 2025 | |
| DXCM DexCom | Initiates: Buy | $102 | $82.93 | +23.00% | 1 | Jun 16, 2025 | |
| PODD Insulet | Initiates: Buy | $365 | $301.05 | +21.24% | 1 | Jun 16, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $26 | $13.52 | +92.31% | 1 | Jun 16, 2025 | |
| GMED Globus Medical | Maintains: Hold | $80 → $68 | $59.17 | +14.92% | 27 | May 12, 2025 | |
| LNTH Lantheus Holdings | Maintains: Buy | $127 → $117 | $80.42 | +45.49% | 18 | May 8, 2025 | |
| TFX Teleflex | Maintains: Hold | $140 → $137 | $119.90 | +14.26% | 38 | May 5, 2025 | |
| SYK Stryker | Maintains: Hold | $390 → $400 | $395.28 | +1.19% | 20 | May 5, 2025 | |
| GKOS Glaukos | Reiterates: Buy | $140 → $135 | $103.50 | +30.43% | 5 | May 1, 2025 | |
| ITGR Integer Holdings | Maintains: Buy | $140 → $150 | $121.00 | +23.97% | 7 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $113 → $117 | $104.32 | +12.15% | 12 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $605 → $590 | $544.47 | +8.36% | 28 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $70 | $57.92 | +20.86% | 14 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $61 → $51 | $41.74 | +22.18% | 3 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $9.5 → $8 | $6.18 | +29.45% | 14 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $93 → $90 | $88.39 | +1.82% | 15 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $26 → $24 | $22.48 | +6.76% | 10 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $26 → $19 | $13.49 | +40.85% | 18 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $78 → $75 | $76.79 | -2.33% | 18 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $111 → $145 | $142.47 | +1.78% | 16 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $235 | $128.48 | +82.91% | 24 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $118 → $113 | $93.67 | +20.64% | 32 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $285 | $251.06 | +13.52% | 5 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $21 | $18.47 | +13.70% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $13.05 | +53.26% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $71 → $82 | $87.78 | -6.58% | 5 | Aug 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $260 → $250 | $176.16 | +41.92% | 5 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $27 → $26 | $4.25 | +511.76% | 4 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $690 → $770 | $196.82 | +291.22% | 10 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $94 → $85 | $64.78 | +31.21% | 6 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $13.16 | +51.98% | 1 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $27 | $10.93 | +147.03% | 5 | Feb 23, 2021 |
Tandem Diabetes Care
Jun 16, 2025
Initiates: Hold
Price Target: $24
Current: $16.78
Upside: +43.03%
DexCom
Jun 16, 2025
Initiates: Buy
Price Target: $102
Current: $82.93
Upside: +23.00%
Insulet
Jun 16, 2025
Initiates: Buy
Price Target: $365
Current: $301.05
Upside: +21.24%
Beta Bionics
Jun 16, 2025
Initiates: Buy
Price Target: $26
Current: $13.52
Upside: +92.31%
Globus Medical
May 12, 2025
Maintains: Hold
Price Target: $80 → $68
Current: $59.17
Upside: +14.92%
Lantheus Holdings
May 8, 2025
Maintains: Buy
Price Target: $127 → $117
Current: $80.42
Upside: +45.49%
Teleflex
May 5, 2025
Maintains: Hold
Price Target: $140 → $137
Current: $119.90
Upside: +14.26%
Stryker
May 5, 2025
Maintains: Hold
Price Target: $390 → $400
Current: $395.28
Upside: +1.19%
Glaukos
May 1, 2025
Reiterates: Buy
Price Target: $140 → $135
Current: $103.50
Upside: +30.43%
Integer Holdings
Apr 28, 2025
Maintains: Buy
Price Target: $140 → $150
Current: $121.00
Upside: +23.97%
Apr 24, 2025
Maintains: Buy
Price Target: $113 → $117
Current: $104.32
Upside: +12.15%
Apr 23, 2025
Maintains: Buy
Price Target: $605 → $590
Current: $544.47
Upside: +8.36%
Apr 11, 2025
Maintains: Buy
Price Target: $90 → $70
Current: $57.92
Upside: +20.86%
Apr 11, 2025
Maintains: Buy
Price Target: $61 → $51
Current: $41.74
Upside: +22.18%
Apr 11, 2025
Maintains: Hold
Price Target: $9.5 → $8
Current: $6.18
Upside: +29.45%
Apr 11, 2025
Maintains: Hold
Price Target: $93 → $90
Current: $88.39
Upside: +1.82%
Apr 11, 2025
Maintains: Hold
Price Target: $26 → $24
Current: $22.48
Upside: +6.76%
Apr 11, 2025
Maintains: Hold
Price Target: $26 → $19
Current: $13.49
Upside: +40.85%
Apr 11, 2025
Maintains: Hold
Price Target: $78 → $75
Current: $76.79
Upside: -2.33%
Feb 21, 2025
Maintains: Buy
Price Target: $111 → $145
Current: $142.47
Upside: +1.78%
Feb 11, 2025
Maintains: Buy
Price Target: $250 → $235
Current: $128.48
Upside: +82.91%
Feb 10, 2025
Reiterates: Hold
Price Target: $118 → $113
Current: $93.67
Upside: +20.64%
Dec 18, 2024
Maintains: Buy
Price Target: $240 → $285
Current: $251.06
Upside: +13.52%
Jan 31, 2023
Maintains: Buy
Price Target: $17 → $21
Current: $18.47
Upside: +13.70%
Aug 24, 2021
Initiates: Outperform
Price Target: $20
Current: $13.05
Upside: +53.26%
Aug 19, 2021
Maintains: Market Perform
Price Target: $71 → $82
Current: $87.78
Upside: -6.58%
Aug 6, 2021
Maintains: Market Perform
Price Target: $260 → $250
Current: $176.16
Upside: +41.92%
May 11, 2021
Maintains: Outperform
Price Target: $27 → $26
Current: $4.25
Upside: +511.76%
Apr 29, 2021
Maintains: Outperform
Price Target: $690 → $770
Current: $196.82
Upside: +291.22%
Apr 29, 2021
Maintains: Outperform
Price Target: $94 → $85
Current: $64.78
Upside: +31.21%
Feb 24, 2021
Initiates: Outperform
Price Target: $20
Current: $13.16
Upside: +51.98%
Feb 23, 2021
Maintains: Outperform
Price Target: $23 → $27
Current: $10.93
Upside: +147.03%